학술논문

Phase I trial of in situ vaccination with autologous CCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS1096-pS1097, 2p. Supplement: 7
Subject
Language
English
ISSN
15698041